United States· US:50090-5467_68b8dd5a-c40a-4004-97c3-c989f85bba82
Trulicity
A dulaglutide product containing dulaglutide, registered in United States by A-S Medication Solutions. The same ATC class is registered in 14 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Dulaglutide is registered in 14 of 19 countries.
Countries holding a registration under ATC A10BJ05 (dulaglutide), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 10 of them publish a price we can compare per daily dose
Dulaglutide · ATC A10BJ05
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dulaglutide costs, country by country.
Normalised to the WHO defined daily dose (0.16 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dulaglutide · price per daily dose (0.16 mg)
USD · FX 28 Sept 2026
- CH Switzerland$7.61
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DULAGLUTIDE
- Manufacturer
- A-S Medication Solutions
- Country
- United States (US)
- ATC code
- A10BJ05
- ATC class
- Dulaglutide
- Defined daily dose
- 0.16 mg, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1150090546704 SYRINGE in 1 CARTON (50090-5467-0) / .5 mL in 1 SYRINGE
- ndc1150090-5467-0
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
301 interactions on record for dulaglutide.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dulaglutide · interactions on record
301 records
- 3 severe
- 257 moderate
- 41 minor
Most severe, free to view
- GatifloxacinJ01MA16severe
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dulaglutide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTRULICITYEli Lilly Nederland B.V., Utrecht
- FinlandTrulicityEli Lilly Nederland B.V.
- NorwayTrulicityEli Lilly and Company Limited
- BelgiumTrulicity 0.75 mgEli Lilly Nederland
- United KingdomTrulicity 0.75mg/0.5ml solution for injection pre-filled pensPharmaram Ltd
- IcelandTrulicityEli Lilly Nederland B.V.*
- NetherlandsTrulicity 0,75 mg oplossing voor injectie in voorgevulde injectiespuitEli Lilly Nederland BV
- SwedenTrulicity 0,75 mg Injektionsvätska, lösning i förfylld injektionspennaEli Lilly Nederland B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Trulicity
- Liechtenstein · Trulicity
- Norway · Trulicity
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dabb8615-48c5-4d01-b966-38208e67ca9a GET /v1/drugs/dabb8615-48c5-4d01-b966-38208e67ca9a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "SUBCUTANEOUS",
"source": "ndc",
"strength": "3",
"substance": "DULAGLUTIDE",
"productndc": "50090-5467",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/.5mL",
"application_number": "BLA125469",
"marketing_category": "BLA"
}See everything about dulaglutide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.